Mamadou Camara

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis

Anneli Cooper, Hamidou Ilboudo, Vincent Pius Alibu et al. · eLife · 2017 · 128 citations · Full text

Life Sciences, Genetics, Infectious Diseases +17

Reducing Human-Tsetse Contact Significantly Enhances the Efficacy of Sleeping Sickness Active Screening Campaigns: A Promising Result in the Context of Elimination

Fabrice Courtin, Mamadou Camara, Jean-Baptiste Rayaissé et al. · PLoS neglected tropical diseases · 2015 · 126 citations · Full text

Life Sciences, Infectious Disease Control, Infectious Diseases +17

Population genomics reveals the origin and asexual evolution of human infective trypanosomes

William Weir, Paul Capewell, Bernardo J. Foth et al. · eLife · 2016 · 122 citations · Full text

Life Sciences, Evolutionary Biology, Genetics +17

Efficacy and safety of acoziborole in patients with human African trypanosomiasis caused by Trypanosoma brucei gambiense: a multicentre, open-label, single-arm, phase 2/3 trial

Victor Kande Betu Kumeso, Wilfried Mutombo Kalonji, Sandra Rembry et al. · The Lancet Infectious Diseases · 2022 · 116 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Population genetics of <i>Trypanosoma brucei gambiense</i> , the agent of sleeping sickness in Western Africa

Mathurin Koffi, Thierry De Meeûs, Bruno Bucheton et al. · Proceedings of the National Academy of Sciences · 2008 · 108 citations · Full text

Life Sciences, Biology, Genetics +13